Menu

Multi Technology Platform

CONTACT US
Play video

V-Series provides solutions suitable for all aesthetic practitioners, from dermatologists, cosmetic and plastic surgeons, general practitioners, and dentists to cosmeticians and Spa owners.

290A6328-min 290A6328-min

V10

Transform your patients from head-to-toe with V10, the RF-based Multi-Technology Platform! V10 is powered by patented and proprietary, clinically proven RF and fractional RF technologies to deliver superior results for greater patient satisfaction.

GET IN TOUCH
290A6290 290A6290

V20

V20 combines cutting edge RF and light therapies with unique handpieces in a single Multi-Technology Platform, allowing for the treatment of the most requested aesthetic procedures, for all skin types, while delivering clinically proven, instant results with little to no downtime. V20 gives you total control and flexibility and build-in combination protocols.

REQUEST A DEMO
290A6277-min 290A6277-min

V30

V30 is a Multi-Technology Platform with “obsolesce” protection and configuration flexibility for a smarter business investment. The platform, incorporates IPL, Laser and RF patented and proprietary Technologies and offers a combination therapy for more effective results, control over depth penetration and unmatchable safety. Each technology is accessible via a different handpiece, and can be acquired separately, so you control your treatment menu.

SPEAK WITH OUR VIRTUAL ACCOUNT MANAGERS

Innovative Solutions

Sinclair has solutions suitable for all aesthetic practitioners, from dermatologists, cosmetic and plastic surgeons, general practitioners, and dentists to cosmeticians and Spa owners.

MAKE AN ENQUIRY
Microsoftteams Image (5) Microsoftteams Image (5)
Handpieces

V-Series

V-FORM

Body counturing & cellulite reduction
V-FR

Fractional RF handpiece
V-IPL

Phototherapy Handpiece with interchangeable filters
V-Nd:YAG

Long pulse Nd:YAG laser handpiece for vascular lesions, skin rejuvenation and hair removal.
V-VR

Vaginal rejuvenation handpiece.
V-ST

Non-Invasive RF-based skin tightening handpiece
GET IN TOUCH
V-Series

Latest articles

Why Joining Sinclair College is a Game Changer

Sinclair College is renowned for its wide array of educational tools and resources, making it a pivotal institution for learners from various backgrounds.
Aesthetic Trends to Watch in 2024

Sinclair's advanced energy-based devices such as Primelase, Sculpt&Shape, and Elysion Pro are setting new standards in aesthetic treatments.
UK Aesthetic Licensing Announced

In a landmark development poised to reshape the landscape of non-surgical cosmetic procedures in the United Kingdom, the government has introduced ambitious plans for a comprehensive licensing scheme.
CONTACT US
Incorporating the V-Series platform into our practice has allowed us to expand into the medical aesthetic market. Using this device, our office has immediate name recognition and credibility due to Sinclair’s outstanding reputation. - Dr. Rosemary Castoreno, MD

V-Series regulations

  1. V-ST
    1. USA - for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation
    2. EU - skin tightening
  2. V-FORM
    1. USA - relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation and temporary reduction in the appearance of cellulite
    2. EU - temporarily reduction of cellulite and Body contouring via temporary circumferences reduction
  3. V-FR
    1. USA - dermatological procedures requiring ablation and resurfacing of the skin
    2. EU - ablation and resurfacing of the skin
  4. V-VR
    1. USA - temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation
    2. EU - electrocoagulation of soft tissues for the treatment of vulvovaginal laxity. The vulva area is referred to the labia majora
  5. V-IPL
    1. USA - Moderate inflammatory acne vulgaris. Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles). Cutaneous lesions including warts, scars and striae. Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte and venous malformations. Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen.
    2. EU - Hair reduction, skin rejuvenation treatment of superficial small vascular and pigmented lesions and treatment of mild to moderate inflammatory acne
  6. V-Nd:YAG
    1. USA - Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias), reticular veins (0.1-4.0 mm dia.) of the leg, rosacea, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas. Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis. Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of Ota, chloasma, verrucae, skin tags and keratosis. Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles. Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Removal of unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen and treatment of pseudofolliculitis barbae (PFB).
    2. EU - hair reduction, treatment of vascular lesions and treatment of onychomycosis